Research

Hormonal

Oral semaglutide significantly improves glycemic control (HbA1c reduction) and promotes weight loss in patients with type 2 diabetes compared to placebo, with efficacy scaling with dosage up to 40mg.

If you have Type 2 Diabetes and struggle with blood sugar or weight, oral semaglutide is a proven, once-daily pill option that works significantly better than a placebo for lowering HbA1c and reducing weight. It is titrated up slowly to minimize stomach upset, which is a common but usually manageable side effect. It is not a substitute for diet and exercise but works alongside them.

StrongSupportsHIGH confidence
Among patients with type 2 diabetes, oral semaglutide resulted in better glycemic control than placebo over 26 weeks... Reductions in body weight were greater with oral semaglutide... vs placebo... and significant for oral semaglutide dosages of 10 mg or more vs placebo
Melanie J. Davies et al. · JAMA · 2017

Why this rating

Randomized, double-blind, placebo-controlled clinical trial with 632 participants.

Source

Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes

Melanie J. Davies et al. · JAMA · 2017

rct · n=632Cited 470×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →